Morgan Stanley’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Buy |
|
|||||
|
2025
Q1 | $1.09K | Hold |
|
|||||
|
2024
Q4 | $1.29K | Hold |
|
|||||
|
2024
Q3 | $874 | Hold |
|
|||||
|
2024
Q2 | $1.46K | Sell |
|
|||||
|
2024
Q1 | $309K | Buy |
|
|||||
|
2023
Q4 | $163K | Buy |
|
|||||
|
2023
Q3 | $60.6K | Sell |
|
|||||
|
2023
Q2 | $170K | Sell |
|
|||||
|
2023
Q1 | $210K | Buy |
|
|||||
|
2022
Q4 | $49.5K | Sell |
|
|||||
|
2022
Q3 | $24K | Hold |
|
|||||
|
2022
Q2 | $26K | Sell |
|
|||||
|
2022
Q1 | $50K | Sell |
|
|||||
|
2021
Q4 | $76K | Sell |
|
|||||
|
2021
Q3 | $148K | Buy |
|
|||||
|
2021
Q2 | $103K | Sell |
|
|||||
|
2021
Q1 | $603K | Sell |
|
|||||
|
2020
Q4 | $2.06M | Buy |
|
|||||
|
2020
Q3 | $937K | Sell |
|
|||||
|
2020
Q2 | $2.49M | Buy |
|
|||||
|
2020
Q1 | $1.09M | Buy |
|
|||||
|
2019
Q4 | $1.45M | Buy |
|
|||||
|
2019
Q3 | $40K | Buy |
|
|||||
|
2019
Q2 | $16K | Sell |
|
|||||
|
2019
Q1 | $83K | Sell |
|
|||||
|
2018
Q4 | $507K | Sell |
|
|||||
|
2018
Q3 | $822K | Sell |
|
|||||
|
2018
Q2 | $1.18M | Buy |
|
|||||
|
2018
Q1 | $179K | Buy |
|
|||||
|
2017
Q4 | $57K | Buy |
|
|||||
|
2017
Q3 | $1K | Sell |
|
|||||
|
2017
Q2 | $85K | Sell |
|
|||||
|
2017
Q1 | $85K | Sell |
|
|||||
|
2016
Q4 | $214K | Buy |
|
|||||
|
2016
Q3 | $16K | Buy |
|
|||||
|
2016
Q2 | $3K | Sell |
|
|||||
|
2016
Q1 | $14K | Sell |
|
|||||
|
2015
Q4 | $32K | Sell |
|
|||||
|
2015
Q3 | $59K | Sell |
|
|||||
|
2015
Q2 | $96K | Hold |
|
|||||
|
2015
Q1 | $100K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $56K | Sell |
|
|||||
|
2014
Q1 | $495K | Buy |
|